Advertisement

Topics

Opioid drugmakers may have to slash production under new DEA proposal

09:25 EDT 9 Aug 2017 | BioPharmaDive

The agency is mulling a 20% reduction in the manufacturing of the Schedule II drugs for 2018.

Original Article: Opioid drugmakers may have to slash production under new DEA proposal

NEXT ARTICLE

More From BioPortfolio on "Opioid drugmakers may have to slash production under new DEA proposal"

Quick Search
Advertisement